Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Hisse Senetlerindeki Sıralama #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Hisse Fiyatı
$0.00047446
Piyasa Değeri
$82.80
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-98.16%
Ülke
FR
Ticaret Neovacs S.A. (ALNEV)

Kategori

Neovacs S.A. (ALNEV) için EPS
December 2024 itibariyle EPS TTM: $-34.55K
Neovacs S.A. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $-34.55K'dir. 2023 yılı sonunda, şirketin EPS'si $-275.26K idi; bu, 2022 yılındaki EPS olan $-1.26 ile önceki yıla göre artış.
Neovacs S.A. için 2007 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
2026 (TTM) $-34.55K 17,504.17%
2024 $-196.26 -99.93%
2023 $-275.26K 21,820,011.06%
2022 $-1.26 -100.00%
2021 $-5.367T -93.96%
2020 $-88.856T -79.32%
2019 $-429.767T -54.85%
2018 $-951.868T -52.78%
2017 $-2.02Qa -24.26%
2016 $-2.66Qa 115.81%
2015 $-1.23Qa -59.95%
2014 $-3.08Qa -17.40%
2013 $-3.73Qa -18.52%
2012 $-4.58Qa -9.86%
2011 $-5.08Qa -27.43%
2010 $-6.99Qa 21.97%
2009 $-5.73Qa 53.05%
2008 $-3.75Qa -7.11%
2007 $-4.03Qa 0.00%
Benzer şirketler veya rakipler için EPS
Şirket EPS EPS Farkı Ülke
$3.62 -100.01%
DK
$15.47 -100.04%
US
$43.12 -100.12%
US
$9.62 -100.03%
BE
$38.32 -100.11%
NL